Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413420
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-05-09
Brief Title:
SUNOSI Solriamfetol Pregnancy Registry
Sponsor:
Axsome Therapeutics Inc
Organization:
Axsome Therapeutics Inc
Study Overview
Official Title:
SUNOSI Solriamfetol Pregnancy Registry An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The SUNOSI solriamfetol Pregnancy Registry is a prospective multi-country observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea OSA
Detailed Description:
The goal of the registry is to provide information on the safety of solriamfetol during pregnancy so that patients and physicians can weigh the benefits and risks of exposure during pregnancy and make informed treatment decisions
The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age The registry is strictly observational Only data that are routinely documented in patients medical records during the course of usual care will be collected
The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age The registry is strictly observational Only data that are routinely documented in patients medical records during the course of usual care will be collected
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None